2 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Withdrawn 2 |
Follow Vestibular Schwannoma: new trials by email Literature Review of Vestibular Schwannoma trials Research Report on Vestibular Schwannoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function Gentamicin - Vestibular Schwannoma | Phase 4 | Withdrawn | Lund University | 2015-04-01 | 2020-09-11 | |
| Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function Gentamicins - Vestibular Schwannoma | Phase 4 | Withdrawn | Lund University | 2015-01-01 | 2020-09-11 |
Cranial Nerve Diseases (2) · Cranial Nerve Neoplasms (2) · Ear Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Nerve Sheath Neoplasms (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2) · Neurilemmoma (2) · Neuroectodermal Tumors (2) · Neuroendocrine Tumors (2) · Neuroma (2)
Gentamicins (2)
Lund University (2)
Sweden (2)
PMID 17917842, PMID 19574236, PMID 19645909, PMID 22027076, PMID 18607963